Connection

Jean-Charles Soria to Proteasome Inhibitors

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Proteasome Inhibitors.
Jean-Charles Soria
Connection Strength
0.165
Proteasome Inhibitors
  1. Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors. Invest New Drugs. 2018 08; 36(4):619-628.
    View in: PubMed
    Score: 0.165
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.